Compare The Coca-Cola Co K (KO) vs Revvity Inc (RVTY) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
The Coca-Cola Co K vs Revvity Inc — how do they compare? The Coca-Cola Co K trades at $86.72 (market cap $372.08B), while Revvity Inc trades at $117.6 (market cap $12.91B). The key difference: The Coca-Cola Co K is far larger — about 28.8× Revvity Inc's market cap, and The Coca-Cola Co K pays the higher dividend (2.45%). Which is the better fit depends on your goals.
| KO | RVTY | |
|---|---|---|
Market Cap | $372.08B | $12.91B |
Volume | 14,630,257 | — |
Sector | Consumer Staples | Technology |
52-Week High | $89.08 | $117.75 |
52-Week Low | $65.67 | $82.26 |
Enterprise Value | $399.26B | $15.23B |
Dividend Yield | 2.45% | 0.24% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Coca-Cola (KO) trades at $86.67, down 0.23% on the day, with a bullish technical signal driven by moving averages and strong support at $85. The company reported robust earnings beats in recent quarters, with Q2 2026 EPS of $0.97 exceeding expectations, and maintains high profitability margins, including a 28.56% net income margin. Recent news highlights institutional buying and stable demand trends, while the upcoming Q3 2026 earnings are anticipated at $0.87 EPS.
The stock offers a compelling dividend yield with 64 consecutive years of increases, supported by solid cash flow and a consensus price target of $95.83 implying 10.6% upside. Risks include regional demand volatility in Asia and high debt levels, but analyst sentiment is bullish with 60% buy ratings. Long-term growth prospects remain intact given brand strength and global footprint.
RVTY trades at $117.88, up 1.6% today, with a bullish technical outlook and strong earnings momentum after beating Q2 2026 EPS estimates. The stock is near the consensus price target of $120.50, supported by a 51.72% analyst buy rating. Recent news highlights product launches like the SuperFlex prenatal system and investor conference participation, reinforcing growth prospects in diagnostics and biotech tools.
The outlook remains positive with revenue stability and margin strength, but elevated P/E of 55.64 poses valuation risk. Key opportunities include diagnostic demand and AI-driven workflows, while risks involve competitive pressures and execution challenges. Net cash flow turned positive in 2026, signaling improved financial health.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About The Coca-Cola Co K
The Coca-Cola Company manufactures, markets, and distributes soft drink concentrates and syrups. The Company also distributes and markets juice and juice-drink products. Coca-Cola distributes its products to retailers and wholesalers in the United States and internationally.
Read more on KO →About Revvity Inc
Revvity, Inc., formerly the Life Sciences and Diagnostics businesses of PerkinElmer, is a global provider of scientific and diagnostic solutions. The company focuses on the health and wellness of humanity through its expertise in life science research, detection, imaging, and informatics. Revvity supplies a broad portfolio of instruments, reagents, and services to pharmaceutical companies, academic research institutions, and clinical laboratories worldwide, enabling customers to make advancements in human health.
Read more on RVTY →
